Acute monoblastic/monocytic leukemia, in remission digital illustration

Acute monoblastic/monocytic leukemia, in remission Save


ICD-10 code: C93.01

Disease category: C93.0: Acute monoblastic/monocytic leukemia

Acute Monoblastic/Monocytic Leukemia, in Remission: Understanding the Condition

Acute monoblastic/monocytic leukemia, in remission, is a rare form of blood cancer that affects the bone marrow and blood cells. It primarily occurs when abnormal cells, known as monoblasts or monocytic blasts, rapidly multiply and crowd out healthy blood cells. While treatment options for this condition are not discussed here, it's important to understand the nature of the disease and its implications.

1. Classification:

Acute monoblastic/monocytic leukemia falls under the category of acute myeloid leukemia (AML), a type of cancer that starts in the bone marrow and quickly progresses. Within AML, monoblastic/monocytic leukemia is further classified based on the types of cells affected and their characteristics.

2. Symptoms:

Common symptoms of acute monoblastic/monocytic leukemia include fatigue, weakness, frequent infections, fever, easy bruising or bleeding, and bone pain. However, it is important to note that these symptoms can vary from person to person, and some individuals may not experience any symptoms at all. Regular medical check-ups are crucial for early detection and diagnosis.

3. Diagnosis:

Diagnosing acute monoblastic/monocytic leukemia involves various tests, such as a complete blood count (CBC), bone marrow biopsy, and cytogenetic analysis. These tests help determine the presence of abnormal cells, their characteristics, and the extent of the disease. Accurate diagnosis plays a crucial role in developing an appropriate treatment plan.

4. Risk Factors:

While the exact cause of acute monoblastic/monocytic leukemia is unknown, certain risk factors increase the likelihood of developing this condition. These include exposure to high levels of radiation, previous chemotherapy or radiation therapy, certain genetic disorders, and a history of blood disorders. However, it's important to remember that having one or more risk factors does not guarantee the development of this cancer.

5. Prognosis:

Acute monoblastic/monocytic leukemia, in remission, refers to a period where the disease is under control and the patient shows no signs of active cancer. The prognosis for individuals in remission varies depending on several factors, including the patient's overall health, age, response to treatment, and genetic mutations. Regular follow-up appointments are necessary to monitor the disease and ensure its continued remission.

  1. Classification
  2. Symptoms
  3. Diagnosis
  4. Risk Factors
  5. Prognosis

Acute monoblastic/mon

Treatment of Acute monoblastic/monocytic leukemia, in remission:

Treatment Options for Acute Monoblastic/Monocytic Leukemia in Remission

Acute monoblastic/monocytic leukemia, a type of acute myeloid leukemia (AML), is a challenging blood cancer. However, with proper treatment, many patients can achieve remission, allowing them to lead fulfilling lives. Here are some treatment options for individuals in remission from acute monoblastic/monocytic ...

To see full information about treatment please Sign up or Log in